Skip to main content
. 2015 Dec 28;12:S1–S110. doi: 10.1111/j.1470-9465.2006.12_4_1426.x
Outcome
Acute leukemia/BMT
Solid organ cancer/lymphoma
Any AB Quinolone Any AB Quinolone
All cause mortality 0.67 (0.55–0.83) 0.58 (040–0.84) 0.58 (0.33–1.00 0.48 (0.26–0.85)
Febrile neutropenia 0.80 (0.77–0.84) 0.77 (073–0.82) 0.65 (0.55–0.77 0.67 (0.57–0.80)
Clinically documented infections 0.76 (0.69–0.84) 0.75 (064–0.89) 0.59 (0.47–0.73) 0.61 (0.48–0.76)
Any bacteremia 0.55 (0.40–0.62) 0.62 (0 53–0.73) 0.32 (0.17–0.61 0.36 (0.18–0.70)
Gram-negative bacteremia 0.44 (0.35–0 56) 0.36 (0 25–0.50) 0.29 (0.10–0.88) 0.32 (0.09–1.18)
Gram-positive bacteremia 0.71 (0.59–0.86) 0.81 (0 65–1.01) 0.32 (0.12–0.89) 0.35 (0.12–1.04)
Infection-related mortality 0.62 (0.48–0.80) 0.51 (0 31–0.84) 0.65 (0.29–1.46) 0.41 (0.14–1.14)

Relative risks with 95% confidence intervals; AB – antibiotic